We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
See the Zacks Earnings Calendar to stay ahead of market-making news.
EMN surpassed Zacks Consensus Estimate for earnings in each of the last four quarters. It delivered a trailing four-quarter earnings surprise of around 7.7% on average. EMN pulled off an earnings surprise of 6.1% in the last reported quarter.
Eastman is expected to have benefited from cost-cutting and productivity initiatives, as well as its innovation-driven growth strategy in the fourth quarter. Weak demand in certain markets is likely to have weighed on its performance.
EMN stock has gained 9.6% in the past year compared with the Zacks Chemicals Diversified industry’s 1.9% decline.
Image Source: Zacks Investment Research
Let’s see how things are shaping up for this announcement.
What Our Model Unveils for EMN Stock
Our proven model predicts an earnings beat for Eastman Chemical this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earning beat.
Earnings ESP: Earnings ESP for EMN is +0.10%. The Zacks Consensus Estimate for the fourth quarter is currently pegged at $1.58. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: EMN currently carries a Zacks Rank #3.
What Do EMN's Revenue Estimates Say?
The Zacks Consensus Estimate for sales for the to-be-reported quarter is currently pegged at $2,257 million, which implies a rise of around 2.3% from the year-ago reported number.
Our estimate for EMN’s Additives and Functional Products division’s revenues is pegged at $653.8 million, suggesting a rise of 2.2% year over year. The same for the Advanced Materials unit’s revenues is $724 million, indicating an increase of 2.7%.
Our estimate for the Chemical Intermediates segment’s revenues is pinned at $474.8 million, suggesting a year-over-year decline of 7.5%. The same for the Fiber segment stands at $366.8 million, indicating an increase of 6% year over year.
Factors at Play for EMN Stock
Eastman's cost-cutting initiatives are anticipated to have benefited the company in the December quarter. It is expected to have gained from its operational transformation efforts, which are likely to have resulted in lower operating costs. EMN is taking action to keep its manufacturing and administrative costs in control. Pricing initiatives and lower raw material and energy costs are also expected to have supported its bottom line in the fourth quarter.
Innovation and market development initiatives are also expected to have aided EMN’s sales volumes in the quarter to be reported. Eastman aims to increase new business revenues by utilizing its innovation-driven growth strategy. Its specialty portfolio is expected to have supported sales across key end markets.
EMN is exposed to headwinds from weak demand in specific markets. It is seeing soft demand in building & construction and cautious customer behavior in consumer durables and electronics. Demand in building & construction remains sluggish in most regions.
While Eastman Chemical is seeing an end of customer inventory de-stocking across most of its end markets, the same is expected to have continued in medical applications in the fourth quarter. Weaker demand in certain markets is likely to have adversely impacted its performance in the to-be-reported quarter.
Here are some companies in the basic materials space you may want to consider as our model shows they too have the right combination of elements to post an earnings beat this quarter:
The consensus estimate for MEOH’s earnings for the fourth quarter is currently pegged at 91 cents.
ATI Inc. (ATI - Free Report) , slated to release earnings on Feb. 4, has an Earnings ESP of +3.91% and carries a Zacks Rank #3 at present.
The consensus mark for ATI’s fourth-quarter earnings is currently pegged at 60 cents.
Kinross Gold Corporation (KGC - Free Report) , scheduled to release fourth-quarter earnings on Feb. 12, has an Earnings ESP of +36.76%.
The Zacks Consensus Estimate for Kinross Gold's earnings for the fourth quarter is currently pegged at 23 cents. KGC currently carries a Zacks Rank #3.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Eastman Chemical to Post Q4 Earnings: What's in Store for the Stock?
Key Takeaways
Eastman Chemical Company (EMN - Free Report) is scheduled to release fourth-quarter 2024 results after the closing bell on Jan. 30.
See the Zacks Earnings Calendar to stay ahead of market-making news.
EMN surpassed Zacks Consensus Estimate for earnings in each of the last four quarters. It delivered a trailing four-quarter earnings surprise of around 7.7% on average. EMN pulled off an earnings surprise of 6.1% in the last reported quarter.
Eastman is expected to have benefited from cost-cutting and productivity initiatives, as well as its innovation-driven growth strategy in the fourth quarter. Weak demand in certain markets is likely to have weighed on its performance.
EMN stock has gained 9.6% in the past year compared with the Zacks Chemicals Diversified industry’s 1.9% decline.
Let’s see how things are shaping up for this announcement.
What Our Model Unveils for EMN Stock
Our proven model predicts an earnings beat for Eastman Chemical this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earning beat.
Earnings ESP: Earnings ESP for EMN is +0.10%. The Zacks Consensus Estimate for the fourth quarter is currently pegged at $1.58. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: EMN currently carries a Zacks Rank #3.
What Do EMN's Revenue Estimates Say?
The Zacks Consensus Estimate for sales for the to-be-reported quarter is currently pegged at $2,257 million, which implies a rise of around 2.3% from the year-ago reported number.
Our estimate for EMN’s Additives and Functional Products division’s revenues is pegged at $653.8 million, suggesting a rise of 2.2% year over year. The same for the Advanced Materials unit’s revenues is $724 million, indicating an increase of 2.7%.
Our estimate for the Chemical Intermediates segment’s revenues is pinned at $474.8 million, suggesting a year-over-year decline of 7.5%. The same for the Fiber segment stands at $366.8 million, indicating an increase of 6% year over year.
Factors at Play for EMN Stock
Eastman's cost-cutting initiatives are anticipated to have benefited the company in the December quarter. It is expected to have gained from its operational transformation efforts, which are likely to have resulted in lower operating costs. EMN is taking action to keep its manufacturing and administrative costs in control. Pricing initiatives and lower raw material and energy costs are also expected to have supported its bottom line in the fourth quarter.
Innovation and market development initiatives are also expected to have aided EMN’s sales volumes in the quarter to be reported. Eastman aims to increase new business revenues by utilizing its innovation-driven growth strategy. Its specialty portfolio is expected to have supported sales across key end markets.
EMN is exposed to headwinds from weak demand in specific markets. It is seeing soft demand in building & construction and cautious customer behavior in consumer durables and electronics. Demand in building & construction remains sluggish in most regions.
While Eastman Chemical is seeing an end of customer inventory de-stocking across most of its end markets, the same is expected to have continued in medical applications in the fourth quarter. Weaker demand in certain markets is likely to have adversely impacted its performance in the to-be-reported quarter.
Eastman Chemical Company Price and EPS Surprise
Eastman Chemical Company price-eps-surprise | Eastman Chemical Company Quote
Basic Materials Stocks That Warrant a Look
Here are some companies in the basic materials space you may want to consider as our model shows they too have the right combination of elements to post an earnings beat this quarter:
Methanex Corporation (MEOH - Free Report) , slated to release earnings on Jan. 29, has an Earnings ESP of +29.28% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for MEOH’s earnings for the fourth quarter is currently pegged at 91 cents.
ATI Inc. (ATI - Free Report) , slated to release earnings on Feb. 4, has an Earnings ESP of +3.91% and carries a Zacks Rank #3 at present.
The consensus mark for ATI’s fourth-quarter earnings is currently pegged at 60 cents.
Kinross Gold Corporation (KGC - Free Report) , scheduled to release fourth-quarter earnings on Feb. 12, has an Earnings ESP of +36.76%.
The Zacks Consensus Estimate for Kinross Gold's earnings for the fourth quarter is currently pegged at 23 cents. KGC currently carries a Zacks Rank #3.